FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1694896802> ?p ?o ?g. }

• W1694896802 endingPage "380" @default.
• W1694896802 startingPage "375" @default.
• W1694896802 abstract "Objective To compare the tolerability and clinical efficacy of tolterodine and oxybutynin in the treatment of Hong Kong Chinese women with an overactive bladder. Patients and methods A randomized controlled trial was conducted at two urogynaecology centres in Hong Kong. In all, 106 women with urodynamically confirmed detrusor instability were recruited. Baseline severity assessments included a visual analogue scale (VAS), urinary diary and urinary pad-test. The women were randomized to receive either oral tolterodine 2 mg or oxybutynin 5 mg twice daily for 10 weeks. Treatment responses were assessed at 4 and 10 weeks using the VAS and urinary diary. Treatment tolerability was assessed at baseline, 4 and 10 weeks using the Xerostomia Questionnaire. A urinary pad-test was repeated at 10 weeks. Results The perceived change from baseline VAS was better in the tolterodine than the oxybutynin group after 10 weeks of treatment (per-protocol analysis, P = 0.043). The two drugs were effective in reducing the symptoms of frequency (P < 0.001). Tolterodine was significantly better than oxybutynin in reducing urinary leakage (urinary pad-test; median change - 5.00 g vs 0 g, P = 0.019). Both drugs caused a significant worsening of dry mouth (overall dryness, P < 0.005; discomfort, P < 0.005; sleep, P = 0.021; speaking, P = 0.045; swallowing, P = 0.004; and liquid consumption, P = 0.017). Conclusions Both oxybutynin and tolterodine were effective in ameliorating the severity of the symptoms of detrusor instability. Tolterodine was better than oxybutynin in both subjective and objective outcome measures, but both drugs caused similar worsening of dry mouth that may limit the tolerability of these medications." @default.
• W1694896802 created "2016-06-24" @default.
• W1694896802 creator A5015986526 @default.
• W1694896802 creator A5016222393 @default.
• W1694896802 creator A5020424520 @default.
• W1694896802 creator A5026084922 @default.
• W1694896802 creator A5043112592 @default.
• W1694896802 creator A5045309367 @default.
• W1694896802 creator A5068310654 @default.
• W1694896802 date "2002-08-14" @default.
• W1694896802 modified "2023-10-18" @default.
• W1694896802 title "A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder" @default.
• W1694896802 cites W1410775549 @default.
• W1694896802 cites W1501940611 @default.
• W1694896802 cites W1967031158 @default.
• W1694896802 cites W1977586210 @default.
• W1694896802 cites W1978283734 @default.
• W1694896802 cites W1988220187 @default.
• W1694896802 cites W2008079238 @default.
• W1694896802 cites W2010109877 @default.
• W1694896802 cites W2023939615 @default.
• W1694896802 cites W2024975356 @default.
• W1694896802 cites W2083510953 @default.
• W1694896802 cites W2088647881 @default.
• W1694896802 cites W2088679190 @default.
• W1694896802 cites W2109298103 @default.
• W1694896802 cites W2122951581 @default.
• W1694896802 cites W2141823090 @default.
• W1694896802 cites W2169544570 @default.
• W1694896802 cites W2337821609 @default.
• W1694896802 doi "https://doi.org/10.1046/j.1464-410x.2002.02905.x" @default.
• W1694896802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12175392" @default.
• W1694896802 hasPublicationYear "2002" @default.
• W1694896802 type Work @default.
• W1694896802 sameAs 1694896802 @default.
• W1694896802 citedByCount "36" @default.
• W1694896802 countsByYear W16948968022012 @default.
• W1694896802 countsByYear W16948968022014 @default.
• W1694896802 countsByYear W16948968022015 @default.
• W1694896802 countsByYear W16948968022016 @default.
• W1694896802 countsByYear W16948968022017 @default.
• W1694896802 countsByYear W16948968022021 @default.
• W1694896802 countsByYear W16948968022023 @default.
• W1694896802 crossrefType "journal-article" @default.
• W1694896802 hasAuthorship W1694896802A5015986526 @default.
• W1694896802 hasAuthorship W1694896802A5016222393 @default.
• W1694896802 hasAuthorship W1694896802A5020424520 @default.
• W1694896802 hasAuthorship W1694896802A5026084922 @default.
• W1694896802 hasAuthorship W1694896802A5043112592 @default.
• W1694896802 hasAuthorship W1694896802A5045309367 @default.
• W1694896802 hasAuthorship W1694896802A5068310654 @default.
• W1694896802 hasConcept C126322002 @default.
• W1694896802 hasConcept C126894567 @default.
• W1694896802 hasConcept C14184104 @default.
• W1694896802 hasConcept C142724271 @default.
• W1694896802 hasConcept C168563851 @default.
• W1694896802 hasConcept C197934379 @default.
• W1694896802 hasConcept C204787440 @default.
• W1694896802 hasConcept C2777844464 @default.
• W1694896802 hasConcept C2778375690 @default.
• W1694896802 hasConcept C2778531004 @default.
• W1694896802 hasConcept C2778941218 @default.
• W1694896802 hasConcept C2781020410 @default.
• W1694896802 hasConcept C42219234 @default.
• W1694896802 hasConcept C71924100 @default.
• W1694896802 hasConcept C77411442 @default.
• W1694896802 hasConceptScore W1694896802C126322002 @default.
• W1694896802 hasConceptScore W1694896802C126894567 @default.
• W1694896802 hasConceptScore W1694896802C14184104 @default.
• W1694896802 hasConceptScore W1694896802C142724271 @default.
• W1694896802 hasConceptScore W1694896802C168563851 @default.
• W1694896802 hasConceptScore W1694896802C197934379 @default.
• W1694896802 hasConceptScore W1694896802C204787440 @default.
• W1694896802 hasConceptScore W1694896802C2777844464 @default.
• W1694896802 hasConceptScore W1694896802C2778375690 @default.
• W1694896802 hasConceptScore W1694896802C2778531004 @default.
• W1694896802 hasConceptScore W1694896802C2778941218 @default.
• W1694896802 hasConceptScore W1694896802C2781020410 @default.
• W1694896802 hasConceptScore W1694896802C42219234 @default.
• W1694896802 hasConceptScore W1694896802C71924100 @default.
• W1694896802 hasConceptScore W1694896802C77411442 @default.
• W1694896802 hasIssue "4" @default.
• W1694896802 hasLocation W16948968021 @default.
• W1694896802 hasLocation W16948968022 @default.
• W1694896802 hasOpenAccess W1694896802 @default.
• W1694896802 hasPrimaryLocation W16948968021 @default.
• W1694896802 hasRelatedWork W1983371621 @default.
• W1694896802 hasRelatedWork W1994231517 @default.
• W1694896802 hasRelatedWork W2047422349 @default.
• W1694896802 hasRelatedWork W2049444610 @default.
• W1694896802 hasRelatedWork W2069015817 @default.
• W1694896802 hasRelatedWork W2240000265 @default.
• W1694896802 hasRelatedWork W2297239795 @default.
• W1694896802 hasRelatedWork W2341135423 @default.
• W1694896802 hasRelatedWork W2358091684 @default.
• W1694896802 hasRelatedWork W2406257615 @default.
• W1694896802 hasVolume "90" @default.
• W1694896802 isParatext "false" @default.

• next